KMKarina Motolko

Karina Motolko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karina Motolko has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automated Recognition of Abnormalities in Gastrointestinal Endoscopic Images – Evaluation of an AI Tool for Identifying Polyps and Other Irregularities

    by Weronika Jarych, Elżbieta Tokarczyk, Patryk Iglewski, Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Michał Kociński, Jan Reinald Wendt

    This study investigates the application of artificial intelligence (AI) for the automatic detection of pathological abnormalities in gastrointestinal endoscopic images. Specifically, it evaluates the performance of an AI tool in identifying and classifying lesions such as polyps and other irregularities, including inflammatory changes, within real-time endoscopic procedures. The primary objective is to assess the tool's diagnostic accuracy and its potential to improve lesion detection, thereby reducing the likelihood of overlooked abnormalities. Leveraging advanced machine learning techniques, particularly convolutional neural networks (CNNs), the AI system aims to enhance diagnostic precision and support clinicians in making prompt, evidence-based decisions. Key advantages of AI integration in endoscopy include improved sensitivity, minimized detection errors, and the potential to optimize clinical workflow efficiency. However, the study also addresses significant challenges, including the necessity for large, heterogeneous datasets for model validation, the need for standardized AI applications, and the ethical implications of AI-assisted clinical decision-making. Additionally, the potential benefits of combining AI with complementary imaging technologies, such as fluorescence imaging and spectroscopy, are explored to further enhance diagnostic capabilities. In conclusion, the study highlights the promising role of AI in gastrointestinal endoscopy while underscoring the importance of continued research, algorithmic refinement, and the establishment of regulatory frameworks to fully harness its clinical potential.

  • Open Access

    The role of Artificial Intelligence in detecting breast lesions using ultrasound

    by Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Elżbieta Tokarczyk, Martyna Michalska, Adam Łabuda

    Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.

  • Open Access

    Advancements in Corneal Transplantation: Addressing Rejection Risks, Innovations and Challenges

    by Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Elżbieta Tokarczyk

    Introduction and Objective: Corneal transplantation is an increasingly common surgical procedure, with lamellar keratoplasty now favored over penetrating keratoplasty due to its advantages in outcomes and precision. Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "corneal transplantation rejection" and "high risk of rejection," underscores the need for advancements in understanding and managing graft rejection. Brief knowledge status: Key insights highlight the importance of deeper exploration into the immunological mechanisms of rejection to refine therapeutic strategies. The development of bioengineered materials like acellular porcine corneal stroma (APCS) offers a promising solution to the global donor shortage, though further validation of their clinical utility is needed. Complementary therapies such as amniotic membrane transplantation show promise in mitigating graft failure and treating corneal surface disorders due to their anti-inflammatory and regenerative properties. Moreover, comparative studies suggest that advanced keratoplasty techniques, such as Descemet Membrane Endothelial Keratoplasty (DMEK), may achieve lower rejection rates compared to alternatives like Descemet Stripping Automated Endothelial Keratoplasty (DSAEK). Discussion: Future priorities include advancing drug delivery systems, ensuring the feasibility and accessibility of bioengineered materials, and conducting large-scale multicenter trials to validate novel treatments and surgical methods across diverse populations. Summary: Addressing these challenges is particularly crucial for high-risk and pediatric patients, with the ultimate goal of reducing graft failure rates and the necessity for repeat interventions.